Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jun 12, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000072.pdf 0001708138-20-000072.xls
Jun 12, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000071.pdf 0001708138-20-000071.xls
Jun 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001140361-20-013625.pdf 0001140361-20-013625.xls
Jun 10, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-20-001593.pdf
Jun 10, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000068.pdf 0001708138-20-000068.xls
Jun 09, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000023.pdf 0001237899-20-000023.xls
Jun 08, 2020	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-20-070667.pdf 0001104659-20-070667.xls
Jun 05, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000022.pdf 0001237899-20-000022.xls
Jun 02, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000066.pdf 0001708138-20-000066.xls
Jun 01, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000064.pdf 0001708138-20-000064.xls

Data provided by Kaleidoscope.

Investors & Media